CAS No. |
93800-59-0 |
中文名称 |
8α,9α-环氧coleon-U-醌 |
英文名称 |
8α,9α-Epoxycoleon-U-quinone |
别名 |
Phenanthro[4a,8a-b]oxirene-2,8,11(4H)-trione, 5,6,7,7a-tetrahydro-3,9-dihydroxy-4,4,7a-trimethyl-10-(1-methylethyl)-, (1aR,7aS,7bS)- (9CI);Phenanthro[4a,8a-b]oxirene-2,8,11(4H)-trione, 5,6,7,7a-tetrahydro-3,9-dihydroxy-4,4,7a-trimethyl-10-(1-methylethyl)-, (1aR,7aS,7bS)- |
标准英文名 |
(4aS,4bS,10aR)-3,9-dihydroxy-2-isopropyl-4b,8,8-trimethyl-5,6,7,8-tetrahydro-4a,10a-epoxyphenanthrene-1,4,10(4bH)-trione |
分子式 |
C20H24O6 |
分子量 |
360.41
|
精确分子量 |
360.16
|
SMILES |
CC(C)C1=C(O)C(=O)[C@@]23O[C@@]2(C(=O)C(O)=C2C(C)(C)CCC[C@@]23C)C1=O |
标准SMILES |
CC1(C)CCC[C@@]2(C)C1=C(O)C(=O)[C@@]13O[C@@]21C(=O)C(O)=C(C(C)C)C3=O |
用途 |
8α,9α-Epoxycoleon-U-quinone is a selective (SI = 2.0) P-glycoprotein (P-gp) modulator that effectively inhibits P-gp activity in NCI-H460/R cells; it reverses cancer cell resistance to doxorubicin (DOX) and enhances the anticancer efficacy of DOX when used in combination. |
InChIKey |
AEXKDWVVGVHVQM-ZCNNSNEGSA-N |